Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Educational Grants - Alnylam Pharmaceuticals

    Educational Grants - Alnylam Pharmaceuticals support healthcare professionals and patients through independent education on three rare diseases to advance earlier diagnosis, treatment decisions, and disease management.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Alnylam Pharmaceuticals

    Due Dates: At least 45 days before the activity starts (CME and non-CME) | RFP-specific deadlines

    Funding Amounts: Approved funding may be less than the amount requested

    Summary: Supports independent education for healthcare professionals and patients on ATTR amyloidosis, acute hepatic porphyria, and primary hyperoxaluria type 1.

    Key Information: Only organizations or entities may apply; individuals are ineligible, and government-issued proof of tax status is required.


    Description

    Alnylam Pharmaceuticals supports independent, high-quality educational initiatives that provide healthcare professionals and patients with evidence-based, clinically relevant education to improve patient health. Activities should address unmet educational or community needs, elevate the standard of care, or focus on ongoing research in transthyretin-mediated amyloidosis (ATTR amyloidosis), acute hepatic porphyria (AHP), and primary hyperoxaluria type 1 (PH1).

    Support includes unsolicited continuing medical education (CME) and non-CME requests, as well as independent medical education proposed in response to requests for proposals (RFPs). Priorities include earlier recognition and diagnosis, informed treatment decisions, and improved disease management. Activities may include live conference programs, online educational sessions, educational videos, and newsletters. Supported initiatives must be independently designed and executed.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.